400 related articles for article (PubMed ID: 16313233)
21. Nano-based drug delivery system enhances the oral absorption of lipophilic drugs with extensive presystemic metabolism.
Zhang Z; Gao F; Jiang S; Ma L; Li Y
Curr Drug Metab; 2012 Oct; 13(8):1110-8. PubMed ID: 22380010
[TBL] [Abstract][Full Text] [Related]
22. Chitosan nanoparticles for the oral delivery of tenofovir disoproxil fumarate: formulation optimization, characterization and ex vivo and in vivo evaluation for uptake mechanism in rats.
Shailender J; Ravi PR; Reddy Sirukuri M; Dalvi A; Keerthi Priya O
Drug Dev Ind Pharm; 2018 Jul; 44(7):1109-1119. PubMed ID: 29409342
[TBL] [Abstract][Full Text] [Related]
23. Enhanced oral bioavailability from food protein nanoparticles: A mini review.
Zhang T; Li L; Chunta S; Wu W; Chen Z; Lu Y
J Control Release; 2023 Feb; 354():146-154. PubMed ID: 36566844
[TBL] [Abstract][Full Text] [Related]
24. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
Hunter AC; Elsom J; Wibroe PP; Moghimi SM
Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
[TBL] [Abstract][Full Text] [Related]
25. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
Souto EB; Müller RH
Handb Exp Pharmacol; 2010; (197):115-41. PubMed ID: 20217528
[TBL] [Abstract][Full Text] [Related]
26. The effects of polymeric nanostructure shape on drug delivery.
Venkataraman S; Hedrick JL; Ong ZY; Yang C; Ee PL; Hammond PT; Yang YY
Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1228-46. PubMed ID: 21777633
[TBL] [Abstract][Full Text] [Related]
27. Polymer-based carriers for ophthalmic drug delivery.
Imperiale JC; Acosta GB; Sosnik A
J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
[TBL] [Abstract][Full Text] [Related]
28. pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms.
Liu L; Yao W; Rao Y; Lu X; Gao J
Drug Deliv; 2017 Nov; 24(1):569-581. PubMed ID: 28195032
[TBL] [Abstract][Full Text] [Related]
29. Surface modified nanoparticulate carrier constructs for oral mucosal vaccine delivery.
Mishra N; Singh D; Sharma S; Baldi A
Curr Drug Deliv; 2014; 11(6):729-43. PubMed ID: 25007830
[TBL] [Abstract][Full Text] [Related]
30. A review of biodegradable polymeric systems for oral insulin delivery.
Luo YY; Xiong XY; Tian Y; Li ZL; Gong YC; Li YP
Drug Deliv; 2016 Jul; 23(6):1882-91. PubMed ID: 26066036
[TBL] [Abstract][Full Text] [Related]
31. PLGA nanoparticles in drug delivery: the state of the art.
Bala I; Hariharan S; Kumar MN
Crit Rev Ther Drug Carrier Syst; 2004; 21(5):387-422. PubMed ID: 15719481
[TBL] [Abstract][Full Text] [Related]
32. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
33. Drug-loaded nanocarriers: passive targeting and crossing of biological barriers.
Rabanel JM; Aoun V; Elkin I; Mokhtar M; Hildgen P
Curr Med Chem; 2012; 19(19):3070-102. PubMed ID: 22612696
[TBL] [Abstract][Full Text] [Related]
34. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
Moritz M; Geszke-Moritz M
Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
[TBL] [Abstract][Full Text] [Related]
35. The intestinal uptake of particles and the implications for drug and antigen delivery.
O'Hagan DT
J Anat; 1996 Dec; 189 ( Pt 3)(Pt 3):477-82. PubMed ID: 8982819
[TBL] [Abstract][Full Text] [Related]
36. Nanocarriers for oral drug delivery.
Zhang L; Wang S; Zhang M; Sun J
J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
[TBL] [Abstract][Full Text] [Related]
37. An overview of polymeric dosage forms in buccal drug delivery: State of art, design of formulations and their in vivo performance evaluation.
Fonseca-Santos B; Chorilli M
Mater Sci Eng C Mater Biol Appl; 2018 May; 86():129-143. PubMed ID: 29525088
[TBL] [Abstract][Full Text] [Related]
38. Polysaccharide nanoparticles for oral controlled drug delivery: the role of drug-polymer and interpolymer interactions.
Bianchera A; Bettini R
Expert Opin Drug Deliv; 2020 Oct; 17(10):1345-1359. PubMed ID: 32602795
[No Abstract] [Full Text] [Related]
39. Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.
Silva AC; Santos D; Ferreira D; Lopes CM
Curr Med Chem; 2012; 19(26):4495-510. PubMed ID: 22834821
[TBL] [Abstract][Full Text] [Related]
40. IgG functionalized polymeric nanoparticles for oral insulin administration.
De Marchi JGB; Cé R; Onzi G; Alves ACS; Santarém N; Cordeiro da Silva A; Pohlmann AR; Guterres SS; Ribeiro AJ
Int J Pharm; 2022 Jun; 622():121829. PubMed ID: 35580686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
